Brokers bullish on Satyam, Bajaj Hindusthan

JM Morgan Stanley has kept underweight rating on HPCL, OBC, SCI

JM Morgan Stanley has kept overweight rating on Tata Steel, Sun Pharma

JM Morgan Stanley has kept overweight rating on Arvind Mills, Lupin

CLSA has kept buy rating on Satyam; with a target price of Rs 630

CLSA has kept outperform rating on NTPC; it has upped its target to Rs 110

Citigroup has kept buy rating on Bajaj Hindusthan; with a target price of Rs 216

BRICS Securities has kept neutral rating on Infosys, Satyam, Wipro

BRICS Securities has kept buy rating on HCL Tech, Aztec, Polaris

BRICS Securities has kept sell rating on TCS; with a target price of Rs 1,120

BRICS Securities has kept sell rating on Ranbaxy; with a target price of Rs 421

Angel Broking has kept neutral rating on HLL post Q2CY05 results

Angel Broking has kept buy rating on Nicholas Piramal; with a target price of Rs 325

SSKI has kept underperformer rating on HLL post Q2CY05 results

SSKI has kept outperformer rating on Bank of Baroda, L&T

SSKI has kept underperformer rating on Jet Airways

Pranav Securities has kept buy rating on Surya Pharma; with a target price of Rs 225

Pranav Securities has kept buy rating on Sterling Biotech; with a target price of Rs 160

House	Stocks	Views
JM Morgan Stanley	HPCL, OBC, SCI   Tata Steel, Sun Pharma   Arvind Mills, Lupin	Underweight   Overweight     Overweight
CLSA	Satyam     NTPC	Buy; with a target price of Rs 630   Outperform; upped its target to Rs 110
Citigroup	Bajaj Hindusthan	Buy; with a target price of Rs 216
BRICS Securities	Infosys, Satyam, Wipro   HCL Tech, Aztec, Polaris   TCS     Ranbaxy	Neutral     Buy     Sell; with a target price of Rs 1,120   Sell; with a target price of Rs 421
Angel Broking	HLL   Nicholas Piramal	Neutral   Buy; with a target price of Rs 325
SSKI	HLL   Bank of Baroda, L&T   Jet Airways	Underperformer   Outperformer   Underperformer
Pranav Securities	Surya Pharma     Sterling Biotech	Buy; with a target price of Rs 225   Buy; with a target price of Rs 160